Streetbeat News

Regulatory

BK

BNPQY

HSBC

HSBC Holdings is reportedly partnering with crypto custody technology business, Fireblocks, to expand into the digital asset space. This comes amid regulatory uncertainties in the U.S. crypto sector. HSBC has previously shown interest in the crypto space, launching Bitcoin and Ethereum ETFs and allowing licensed crypto firms to create bank accounts. Fireblocks, which provides a non-custodial wallet-as-a-service, has been a provider of crypto custody instruments for the Bank of New York Mellon and BNP Paribas since early 2021.

Portfolio Pulse from Khyathi Dalal

September 13, 2023 | 9:07 pm

VINE

Fresh Vine Wine has received a notice from NYSE American stating that the company is not in compliance with the NYSE American Continued Listing Standards relating to stockholders' equity.

Portfolio Pulse from Charles Gross

September 13, 2023 | 9:06 pm

ALNY

Alnylam Pharmaceuticals has reported a positive outcome from an FDA Advisory Committee meeting regarding Patisiran, a treatment for the cardiomyopathy of ATTR amyloidosis. The CRDAC voted 9:3 in favor of the benefits of Patisiran outweighing its risks. The FDA has set an action date of October 8, 2023, under the Prescription Drug User Fee Act.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 9:05 pm

ALNY

The FDA advisory committee has voted in favor of a new indication for Alnylam's drug, Onpattro. This positive development could potentially expand the drug's market and boost Alnylam's revenues.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:36 pm

ZOM

Zomedica has received a formal notice from NYSE American stating that it is not in compliance with the exchange's continued listing standard. The company's failure to meet the standard could potentially lead to its delisting.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:34 pm

SCNI

Scinai Immunotherapeutics has reported preclinical results for its innovative plaque psoriasis treatment, NanoAbs. The treatment has shown to downregulate key molecular markers overexpressed in plaque psoriasis and helped the stratum corneum regain a normal appearance in a laboratory 3D skin model. Results from an ex-vivo study in human psoriatic skin are expected in Q4 2023, and in-vivo animal study results are anticipated in early 2024.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:24 pm

CORR

CorEnergy Infrastructure Trust, Inc. (CORR) has received a notice from the New York Stock Exchange (NYSE) regarding its non-compliance with continued listing standards. The company is now subject to the procedures and requirements of the NYSE, which could potentially lead to delisting if compliance is not regained.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:22 pm

SCNI

Scinai Immunotherapeutics has announced results from a preclinical study of IL-17 NanoAbs, which showed downregulated key molecular markers overexpressed in plaque psoriasis.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:21 pm

NVOS

Novo Integrated Sciences' product, IoNovo For Kids, has been granted a registration number and regulatory approval by Turkey's Ministry of Health. The company has also partnered with NOYEM Global Foreign Trade and Consultancy Inc. for distribution in Turkey.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:12 pm

AMD

Advanced Micro Devices, Inc. (AMD) shares closed higher on Wednesday, rebounding from recent losses related to China's tech sector news. The stock has risen by roughly 4% since Monday, despite China's ban on iPhones for official use and competition from Huawei's new smartphones. The rise was not affected by August's hot inflation report, with the broader semiconductor sector responding well.

Portfolio Pulse from Ryan Gustafson

September 13, 2023 | 8:07 pm